Daniel L. Lorber
Chief Tech/Sci/R&D Officer at Diabetes Control Foundation, Inc.
Profile
Daniel L.
Lorber is currently the Medical Director at Diabetes Control Foundation, Inc. and Diabetes Care & Information Center.
He is also an Associate Professor at Weill Cornell Medical College.
Previously, he worked as a Director at Biodel, Inc. from 2004 to 2012, as well as a Director at the American Diabetes Association and the Endocrinology Director at NewYork-Presbyterian.
Lorber earned a doctorate degree from Albert Einstein College of Medicine, Inc.
Daniel L. Lorber active positions
| Companies | Position | Start |
|---|---|---|
| Diabetes Control Foundation, Inc. | Chief Tech/Sci/R&D Officer | 1980-12-31 |
| Diabetes Care & Information Center | Chief Tech/Sci/R&D Officer | 1980-12-31 |
| Weill Cornell Medical College | Corporate Officer/Principal | - |
Former positions of Daniel L. Lorber
| Companies | Position | End |
|---|---|---|
NewYork-Presbyterian/Queens
 NewYork-Presbyterian/Queens Hospital/Nursing ManagementHealth Services NewYork-Presbyterian/Queens provides healthcare services. It also provides services like family health, kidney dialysis, rehabilitation, and dental care. The company was founded on March 13, 1919 and is headquartered in Flushing, NY. | Corporate Officer/Principal | - |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Director/Board Member | - |
Biodel, Inc.
 Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Director/Board Member | - |
Training of Daniel L. Lorber
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Health Technology |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Commercial Services |
NewYork-Presbyterian/Queens
NewYork-Presbyterian/Queens Hospital/Nursing ManagementHealth Services NewYork-Presbyterian/Queens provides healthcare services. It also provides services like family health, kidney dialysis, rehabilitation, and dental care. The company was founded on March 13, 1919 and is headquartered in Flushing, NY. | Health Services |
| Diabetes Control Foundation, Inc. | |
| Diabetes Care & Information Center |
- Stock Market
- Insiders
- Daniel L. Lorber
